FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,944,000 | -13.1% | 51,600 | -60.8% | 0.04% | -23.4% |
| Q4 2020 | $2,237,000 | +262.0% | 131,500 | 0.0% | 0.05% | +235.7% |
| Q3 2020 | $618,000 | -39.2% | 131,500 | -21.0% | 0.01% | -33.3% |
| Q2 2020 | $1,016,000 | +268.1% | 166,500 | +37.0% | 0.02% | +250.0% |
| Q1 2020 | $276,000 | -58.9% | 121,500 | -17.1% | 0.01% | -33.3% |
| Q4 2019 | $672,000 | +246.4% | 146,500 | +193.0% | 0.01% | +200.0% |
| Q3 2019 | $194,000 | -39.0% | 50,000 | +468.2% | 0.00% | -25.0% |
| Q1 2017 | $318,000 | +52.9% | 8,800 | +76.0% | 0.00% | 0.0% |
| Q4 2015 | $208,000 | -66.2% | 5,000 | -87.5% | 0.00% | -69.2% |
| Q3 2015 | $616,000 | -38.0% | 40,000 | 0.0% | 0.01% | -35.0% |
| Q2 2015 | $994,000 | +8.8% | 40,000 | 0.0% | 0.02% | +5.3% |
| Q1 2015 | $914,000 | -50.9% | 40,000 | -42.0% | 0.02% | -54.8% |
| Q4 2014 | $1,863,000 | +169.2% | 69,000 | +16.9% | 0.04% | +147.1% |
| Q3 2014 | $692,000 | +85.5% | 59,000 | +145.8% | 0.02% | +70.0% |
| Q2 2014 | $373,000 | -21.0% | 24,000 | 0.0% | 0.01% | -28.6% |
| Q1 2014 | $472,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|